Pulmonary Function Tests and their Clinical Applications

Suita Williams^*
*Correspondence: Suita Williams, Department of Pulmonary, Critical Care and Sleep Medicine, Stony Brook University, New York, USA, Email:

Introduction

The respiratory system's primary function is to facilitate gas exchange between the atmosphere and the bloodstream. To assess the efficiency of this vital process, pulmonary function tests have become essential tools in the field of respiratory medicine. These tests evaluate lung volumes, airflow rates, gas diffusion capacity, and airway resistance, providing valuable insights into the lung's functional status. The objective of this review is to present a comprehensive analysis of various pulmonary function tests and their relevance in clinical practice.

Description

Spirometry is the most common and basic pulmonary function test. It measures lung volumes and airflow rates, providing critical information on the presence and severity of obstructive and restrictive lung diseases. This section will discuss the methodology, parameters, and interpretation of spirometry. This section will cover the evaluation of total lung capacity, residual volume, functional residual capacity, and other lung volumes and capacities. Understanding these measurements aids in diagnosing restrictive lung diseases and air trapping. As diffusion capacity assesses the ability of the lungs to transfer gas from the alveoli to the bloodstream. It is crucial in diagnosing and monitoring various interstitial lung diseases and pulmonary vascular disorders [1].

Flow-volume loops are graphical representations of expiratory and inspiratory airflow rates. This section will explore how flow-volume loops help in identifying upper airway obstruction, intrathoracic airway obstruction, and fixed or variable airway disorders. These measurements assess the strength of respiratory muscles and are useful in evaluating neuromuscular respiratory diseases. PFTs are essential for diagnosing asthma, assessing its severity, and monitoring the response to bronchodilator therapy [2].

Despite their importance, pulmonary function tests have limitations that must be recognized and considered. Factors such as patient cooperation, effort, and technical issues can affect test results. Additionally, some conditions may not be fully captured by traditional PFTs, necessitating further investigation. Impulse oscillometry is a non-invasive technique that measures respiratory impedance and provides additional information about airway resistance and reactance. This section will explore the principles of IOS and its potential applications in various respiratory conditions. MBW measures the washout of a specific gas, such as nitrogen, during tidal breathing. It is particularly useful in assessing ventilation inhomogeneity and small airway function. This section will discuss the clinical significance of MBW and its potential benefits over traditional tests. Measurement of exhaled nitric oxide is a marker of airway inflammation and is helpful in the management of asthma and other inflammatory airway diseases. This section will delve into the use of eNO as a complementary tool in respiratory assessment.

The treatment for respiratory illnesses that is breathed in is excellent because it can ensure a higher concentration of a medication in the blood and lungs at lower dosages than its oral components, meaning little to no side effects and superior healing outcomes. For instance, inhaling 100–200 g of salbutamol is therapeutically equivalent to taking 2-4 mg orally; hence there is less chance that this treatment will have side effects. Assessing lung function in children requires age-specific reference values and specialized techniques. This section will explore the challenges and adaptations for conducting PFTs in Pediatric patients. Elderly individuals often present unique considerations during pulmonary function testing due to age-related changes in lung function. This section will discuss age-related variations and their implications. For example, salbutamol is administered via inhaler to treat asthma attacks since its effects can be felt immediately. Treatment that is breathed in is risk-free, simple, and patient-friendly. Interpreting PFT results requires comparing measured values to predicted values based on age, sex, height, and race. Z-scores play a crucial role in assessing the severity of lung impairment and monitoring disease progression.

Pulmonary Function Tests (PFTs) are integral to the evaluation and management of respiratory disorders, providing crucial information about lung function and helping clinicians make informed decisions about patient care. In this comprehensive review, we have explored various types of PFTs, their clinical applications, and technological advancements, highlighting their significance in different respiratory conditions. Additionally, we discussed the challenges, limitations, and potential future directions in the field of pulmonary function testing [3].

A multicentre, non-interventional partner study with 954 seriously ill Coronavirus patients demonstrated that inhaled corticosteroids significantly decreased the death rate. In a randomised, open-label Stage 2 study involving 61 patients with mild to moderate Coronavirus illness, it was discovered that inhaled ciclesonide significantly more effectively killed SARS-CoV-2 than the conventional treatment. In a multicenter, open-label, multi-arm, randomised, controlled, multi-stage study involving more than 4700 participants, it was discovered that inhaled budesonide could lengthen recovery time and reduce the risk of mortality. From these tests, it is extremely likely that a more effective compelling treatment for Coronavirus is possible by inhaled medication than oral treatment [4].

One of the key takeaways from this review is the importance of early and accurate diagnosis of respiratory diseases. PFTs play a central role in identifying conditions like asthma, COPD, interstitial lung diseases, and others, allowing for timely intervention and appropriate treatment. Furthermore, they aid in differentiating between obstructive and restrictive patterns, enabling healthcare providers to tailor therapies specific to each patient's condition. The advancements in pulmonary function testing, such as impulse oscillometry (IOS), multiple breath washout (MBW), and exhaled nitric oxide (eNO) measurement, hold great promise for refining respiratory assessments. These novel techniques provide additional insights into airway resistance, reactance, ventilation inhomogeneity, and airway inflammation, potentially improving diagnostic accuracy and disease monitoring. Special populations, such as pediatric and elderly patients, present unique challenges in conducting PFTs. Age-specific reference values and adaptation of testing techniques are essential to account for age-related changes in lung function accurately [5].

Conclusion

Pulmonary function tests are essential tools in the field of respiratory medicine, providing critical information for the diagnosis, monitoring, and management of various lung conditions. As technology continues to evolve, the integration of novel testing techniques and AI algorithms will likely further enhance the accuracy and utility of PFTs. However, to ensure the widespread application of PFTs and optimize patient care globally, standardization and collaboration among healthcare professionals and researchers are essential. By addressing these challenges and embracing technological advancements, we can unlock the full potential of pulmonary function testing and improve respiratory health outcomes for patients worldwide.

Acknowledgement

None.

Conflict of Interest

The authors declare that there is no conflict of interest.

References

1. Hagan, Rachael, Charles J. Gillan, Ivor Spence and Danny McAuley, et al. "Comparing regression and neural network techniques for personalized predictive analytics to promote lung protective ventilation in Intensive Care Units." Comput Biol Med 126 (2020): 104030.

Google Scholar, Crossref, Indexed at

2. Corritori, Suzana, Nikolay Savchuk and David Pauza. “Risk/benefit profiles of currently approved oral antivirals for treatment of covid-19: Similarities and differences.” COVID 2 (2022): 1057-1076.

Google Scholar, Crossref

3. Marchini, Leonardo and Ronald L Ettinger. "COVID‐19 pandemics and oral health care for older adults." Spec Care Dent 40 (2020): 329.

Google Scholar, Crossref, Indexed at

4. Huang, Junqing, Gabriel Tao and Jia-xu Chen, et al. "Current prevention of COVID-19: Natural products and herbal medicine." Front Pharmacol 11 (2020): 588508.

Google Scholar, Crossref, Indexed at

5. Fassihi, Safa C, Neel R Nabar and Reza Fassihi. "Novel approach for low‐dose pulmonary delivery of hydroxychloroquine in COVID‐19." Br J Pharmacol 177 (2020): 4997.

Google Scholar, Crossref, Indexed at